Announcement

New product releasing soon.

Auralief Oral Strips BLOOM Arousal Gel    

Let’s talk about LOVE

Proven for Progress

LOVE Pharma is committed to offering a fresh and trustworthy perspective to the world of health and wellness.

What is Love?

LOVE Pharma specializes in mental health and sexual wellness by licensing and distributing psychedelic and hemp–infused products.

We hold exclusive licenses to produce, market, package, sell, and distribute patent-protected products throughout Europe, North America, and the United Kingdom.

Proprietary & Exclusivity

LOVE Pharma was founded in 2020 as a specialized health and wellness company with exclusive rights to 7 novel therapeutic products focused on sexual and mental wellness.

With a significant portfolio of intellectual property and innovative novel technologies, LOVE plans to enhance everyday life for individuals by offering proven consumer products with scientific data, historical sales, and future growth. LOVE Pharma’s exclusive products are ready to be sold at scale in the global sexual-wellness market.

Acquiring Patents

As an entry point into the burgeoning psychedelics market, LOVE Pharma has acquired the rights to a patent-pending psilocybin strip, which utilizes the already-existing novel technology implemented for the mucoadhesive CBD strip.

Are you an Investor?

View our Investment Centre and how LOVE Pharma can produce significant value for shareholders.

Go to Investor Centre

Team & Board of Directors

Zachary Stadnyk

Director and Chief Executive Officer

Mr. Stadnyk is a corporate finance and advisory professional specializing in taking companies public in emerging markets. Mr. Stadnyk served as the head of corporate finance for The Supreme Cannabis Company from 2014-2018, which raised over $300,000,000 and was later acquired by Canopy Growth in 2021 for $435M. Mr. Stadnyk was the founder, director, and chief executive officer of DC Acquisition Corp, a Capital Pool Company (“CPC”) that raised an initial $3,000,000 on its IPO and listed on the TSX.V. The issuer completed its qualifying transaction with Kiaro Brands, a leading cannabis retailer, in October 2020, which is targeting $50,000,000 in revenue in fiscal 2022. Mr. Stadnyk also serves on the board of Health Logic Interactive (CHIP – TSXV) an early-stage medical device company.

Douglas Taylor

Director

Mr. Taylor has over 30 years of extensive experience in managing projects, services, and facilities in the public sector. His previous work included community engagement, strategic planning, business planning, and implementation for a wide range of recreational facilities and services. Implementation encompassed budgeting, financial planning, auditing, and managing human resources. Mr. Taylor’s degree includes two levels of managerial accounting. He has served on the Glenbriar Board as CEO for three years and as president for the past two and a half years.

Mark Tommasi

Director

Mr. Tommasi has worked as a senior officer, director, financier, and consultant with over 25 years of experience in corporate development, equity, private equity, and venture capital financing, IPO’s and private placements, marketing, investor relations, and board and committee activities for numerous public and private companies (agriculture, technology, junior exploration, and oil and gas) in both the United States and Canada. Mr. Tommasi has been noted for his ability to help young companies get to the next level.

Tatiana Kovaleva

Chief Financial Officer

Ms. Kovaleva is a Vancouver-based finance executive with international and trans-border expertise and credentials as a CPA. Ms. Kovaleva has extensive experience in capital markets, where for over twenty years she served in multiple capacities, including chief financial officer for publicly traded companies such as M Pharmaceutical Inc. and 360 Blockchain Inc. Ms. Kovaleva utilized her specialized executive management experience in public company financial planning and demonstrated a successful track record with timely and accurate financial forecasting, budgeting, reporting, and consolidations, IFRS and GAAP accounting.

Joshua Maurice

Chief Operating Officer

Mr. Maurice has a 20-year background in consumer goods with a focus on OTC drug and nutraceutical development that includes regulatory clinical research, branding, marketing, advertising, and retail distribution on a global basis. Mr. Maurice has successfully launched retail brands from concept to retail distribution with direct-to-consumer campaigns as well as brick-and-mortar clients like Walmart, CVS, Target, Walgreens, and others. Mr. Maurice’s background in operations, sales, and marketing spans across sectors focusing on profitability and revenue growth.